Ruiz Yarimar, Rodrígues Juan, Arvelo Francisco, Usubillaga Alfredo, Monsalve Mariugenia, Diez Nardy, Galindo-Castro Iván
Laboratorio de Genómica y Proteómica, Centro de Biotecnología, Fundación IDEA, Carretera Nacional Hoyo de la Puerta-Baruta, Valle de Sartenejas, Municipio Baruta, Edo. Miranda, Caracas 1015-A, Venezuela.
Phytochemistry. 2008 Jan;69(2):432-8. doi: 10.1016/j.phytochem.2007.07.025. Epub 2007 Sep 14.
ent-Kaurenic acid and many natural derivatives of this diterpene are known to have interesting biological properties. ent-15-Oxo-kaur-16-en-19-oic acid can be easily obtained from grandiflorolic acid which was first isolated from Espeletia grandiflora. The present work describes the proapoptotic effect of ent-15-oxo-kaur-16-en-19-oic acid on the human prostate carcinoma epithelial cell line PC-3 as evidenced by the changes in the expression level of proteins associated with the execution and regulation of apoptosis. Cell viability was affected upon exposure to the compound, the IC(50) were determined as 3.7 microg/ml, which is 4 times lower than that corresponding to a primary cell culture of fibroblasts (14.8 microg/mL). Through Western blot analysis, active forms of caspace-3 associated with the specific proteolysis of Poly(ADP-ribose) polymerase (PARP) were detected. Reduced levels of the antiapoptotic protein Bcl-2, as well as the appearance of internucleosomal DNA fragmentation, were also demonstrated. Thus, ent-15-oxo-kaur-16-en-19-oic acid may be a promising lead compound for new chemopreventive strategies, alone or in combination with traditional chemotherapy agents to overcome drug resistance in tumoral cells.
对映贝壳杉烯酸以及这种二萜的许多天然衍生物都具有有趣的生物学特性。对映 -15-氧代-贝壳杉-16-烯-19-酸可轻松从首次从大花埃斯佩莱蒂亚中分离出的大花酸获得。本研究描述了对映 -15-氧代-贝壳杉-16-烯-19-酸对人前列腺癌上皮细胞系PC-3的促凋亡作用,凋亡执行和调控相关蛋白表达水平的变化证明了这一点。细胞活力在接触该化合物后受到影响,其半数抑制浓度(IC50)测定为3.7微克/毫升,比成纤维细胞原代细胞培养的相应浓度(14.8微克/毫升)低4倍。通过蛋白质印迹分析,检测到与聚(ADP-核糖)聚合酶(PARP)特异性蛋白水解相关的活化形式的半胱天冬酶-3。抗凋亡蛋白Bcl-2水平降低以及核小体间DNA片段化的出现也得到了证实。因此,对映 -15-氧代-贝壳杉-16-烯-19-酸可能是一种有前景的先导化合物,可单独或与传统化疗药物联合用于新的化学预防策略,以克服肿瘤细胞中的耐药性。